🇺🇸 FDA
Patent

US 10428082

Triazole derivatives of melampomagnolide B and methods of use thereof

granted A61KA61K31/4192A61P

Quick answer

US patent 10428082 (Triazole derivatives of melampomagnolide B and methods of use thereof) held by The Regents of the University of Colorado, a body expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a body
Grant date
Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/4192, A61P, A61P35/00